KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Payables: 2009-2024

Historic Payables for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to $171.0 million.

  • Encompass Health's Payables fell 1873.17% to $138.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.4 million, marking a year-over-year decrease of 1873.17%. This contributed to the annual value of $171.0 million for FY2024, which is 58.82% up from last year.
  • As of FY2024, Encompass Health's Payables stood at $171.0 million, which was up 58.82% from $170.0 million recorded in FY2023.
  • Encompass Health's 5-year Payables high stood at $171.0 million for FY2024, and its period low was $115.0 million during FY2020.
  • Over the past 5 years, Encompass Health's median Payables value was $134.0 million (recorded in 2021), while the average stood at $144.6 million.
  • Per our database at Business Quant, Encompass Health's Payables crashed by 82.09% in 2022 and then soared by 2791.57% in 2023.
  • Encompass Health's Payables (Annual) stood at $115.0 million in 2020, then rose by 16.52% to $134.0 million in 2021, then decreased by 0.82% to $132.9 million in 2022, then increased by 27.92% to $170.0 million in 2023, then grew by 0.59% to $171.0 million in 2024.
  • Its last three reported values are $171.0 million in FY2024, $170.0 million for FY2023, and $132.9 million during FY2022.